Search

Your search keyword '"Nakagawa, Masahiro"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Nakagawa, Masahiro" Remove constraint Author: "Nakagawa, Masahiro" Publisher american society of hematology Remove constraint Publisher: american society of hematology
44 results on '"Nakagawa, Masahiro"'

Search Results

1. Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms

2. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms

3. Cooperative Effects of SRSF2 and STAG2 mutations on Development of Myelodysplastic Syndrome and Its Related Disorders

4. Germline Risks and Clinical Impacts of DDX41 Mutations in Myeloid Malignancies

5. Long-Term Clonal Inversion in an MDS-RS Case with Dual SF3B1 Mutations

6. Distinct Pathogenesis of Clonal Hematopoiesis Revealed By Single Cell RNA Sequencing Integrated with Highly Sensitive Genotyping Method

7. Distinct Pathogenesis of Clonal Hematopoiesis Revealed By Single Cell RNA Sequencing Integrated with Highly Sensitive Genotyping Method

9. EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia

12. Distinct Pathogenesis of Clonal Hematopoiesis Revealed By Single Cell RNA Sequencing Integrated with Highly Sensitive Genotyping Method

13. Genotype-Phenotype Relationships and Therapeutic Targets in Acute Erythroid Leukemia

14. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia

15. Novel Molecular Pathogenesis and Therapeutic Target in Acute Erythroid Leukemia

17. Analysis of Clonal Evolution/Heterogeneity of MDS By Simultaneous Detection of Both Mutation and Gene Expression By Single Cell Sequencing

18. Novel and Significant Impact of Germline Variants Predisposed to Pathogenic Somatic Mutations and Loss of Heterozygosity (LOH) in Myelodysplastic Syndromes (MDS) and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

19. DNA Methylation and Genetic Profiles in 320 Patients with Myelodysplastic Syndromes

21. Genome-Wide Analysis of Non-Coding Alterations in Pan-Myeloid Cancers Using Whole Genome Sequencing

22. Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice

24. Stag2 regulates Hematopoietic Differentiation and Self-Renewal

25. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation

27. The Genetic Landscape Of FPD/AML Revealed CDC25C Mutation As a Driver That Promotes Malignant Transformation

30. AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors

35. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins

42. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region

43. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

44. Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF.

Catalog

Books, media, physical & digital resources